WMK News & Events

Reports Q4 revenue $1.29B vs. $1.23B last year. "Despite ongoing cautious customer spending, our Company achieved strong year-over-year sales growth, supported by significant price investments and record capital expenditures that enabled five new store openings and seven major remodels. We also delivered a 21% increase in e-commerce sales while benefitting from elevated pharmacy volume following a competitor's market exit," said Weis Markets, Inc. Chairman, President, and CEO Jonathan H. Weis. "In 2025, long-term investing remained a priority as we continued to support our future growth. Our store, supply chain and support associates helped us improve efficiencies and incorporate technologies that promote a superior customer experience. We are proud of our associates and grateful for their many contributions."

Weis Markets announced that it will delay the filing of its Annual Report on Form 10-K for the 52-week fiscal year ended December 27, 2025. The filing is delayed because the company requires additional time to complete a review and analysis of the impact to, and associated restatement of, its historical financial statements related to the incorrect recording of certain overstated inventory amounts. The company continues to work diligently to complete the remaining review and restatement procedures. The company expects to file its Annual Report on Form 10-K for the 52-week fiscal year ended December 27, 2025, including all required restated financial statements, no later than March 12, 2026; however, the timing of the filing may be subject to further delay, and the company cannot provide assurance regarding the definitive filing date while this work remains in progress. At this time, the company estimates that the incorrect recording of overstated inventory is up to $22M as of the quarter ended September 27, 2025 which is an aggregation of an error that accumulated over multiple reporting periods. As of the quarter ended September 27, 2025, the aggregated estimate amount represents approximately 6.7% of Inventories within Current Assets and approximately 1.1% of Total Assets on the Consolidated Balance Sheet. These estimated adjustments are preliminary, and while the Company currently expects to report such estimated adjustments, there can be no assurance that the final adjustments made as part of any restatement will not differ materially from these estimates. In the interest of providing shareholders with relevant and timely information, the company is disclosing certain preliminary unaudited net sales results. Net sales and other revenue totaled $4.96B for the 52-week fiscal year ended December 27, 2025, compared with $4.79B for the 52-week fiscal year ended December 28, 2024, an increase of 3.5%. Fiscal year 2025 comparable store sales excluding fuel increased 2.1% on an individual year-over-year basis and increased 4% on a two-year stacked basis.

Weis Markets announced the promotion of Bob Gleeson to COO of the company. As COO, Gleeson will oversee the company's merchandising, marketing, advertising, store operations, information technology, asset protection, and pharmacy departments. He will also have oversight of the supply chain departments including distribution, transportation and manufacturing. He will continue to report to Jonathan H. Weis, Chairman, President and CEO of Weis Markets, Inc.